Literature DB >> 9503489

Radiotherapeutic management of bulky cervical lymphadenopathy in squamous cell carcinoma of the head and neck: is postradiotherapy neck dissection necessary?

C R Johnson1, L N Silverman, L B Clay, R Schmidt-Ullrich.   

Abstract

Although traditional recommendations for the management of bulky cervical lymphadenopathy (AJCC categories N2-3) with definitive radiotherapy call for postradiotherapy neck dissection regardless of treatment response, recent data suggests that this policy can be modified on the basis of tumor regression rate. In a series of 130 patients with stage III-IV squamous cell carcinoma of the head and neck managed with a concomitant boost-accelerated hyperfractionated radiotherapy schedule, 81 cases had cervical lymphadenopathy at the time of referral. Patients were analyzed with respect to regional control outcomes for those having complete and incomplete clinical responses during the initial 3-month follow-up interval. The general management policy has been close observation of patients demonstrating complete clinical responses to radiation rather than postradiotherapy neck dissection. Failure patterns were examined in the 58 patients classified as complete responders. Failure occurred in the primary site in 16 (28%) of these patients, while isolated neck failure occurred in only 3 (5%). Neck recurrence rates for patients with maximum lymph node size < or = 3 cm vs. > 3 cm were not statistically different at 3-year follow-up (94% vs. 86%). Among the 23 incomplete clinical responders, 18 had incomplete neck responses. Five of these patients underwent salvage neck dissection; 4 remain clinically free of recurrence. The remaining 13 patients who either refused or were not eligible for salvage surgery ultimately succumbed with persistent loco-regional disease. The policy of observation after complete response to the radiotherapy schedule employed here was associated with a very low incidence of isolated neck failures and was safe and appropriate in patients who can be followed reliably. The prognosis for patients who failed to respond in the neck was poor except for those who underwent salvage surgery.

Entities:  

Mesh:

Year:  1998        PMID: 9503489     DOI: 10.1002/(SICI)1520-6823(1998)6:1<52::AID-ROI6>3.0.CO;2-H

Source DB:  PubMed          Journal:  Radiat Oncol Investig        ISSN: 1065-7541


  6 in total

Review 1.  Treatment of advanced neck metastases.

Authors:  G Spriano; R Pellini; V Manciocco; P Ruscito
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-12       Impact factor: 2.124

2.  CT-based follow-up following radiotherapy or radiochemotherapy for locally advanced head and neck cancer; outcome and development of a prognostic model for regional control.

Authors:  Daan Nevens; Olivier Vantomme; Annouschka Laenen; Robert Hermans; Sandra Nuyts
Journal:  Br J Radiol       Date:  2016-10-06       Impact factor: 3.039

Review 3.  Controversies in management of the neck in head and neck cancer.

Authors:  Madhur Garg; Jonathan J Beitler
Journal:  Curr Treat Options Oncol       Date:  2004-02

4.  Planned neck dissection following radiation treatment for head and neck malignancy.

Authors:  J F Dautremont; M K Brake; G Thompson; J Trites; R D Hart; S M Taylor
Journal:  Int J Otolaryngol       Date:  2012-09-24

5.  Current advances in diagnosis and surgical treatment of lymph node metastasis in head and neck cancer.

Authors:  A Teymoortash; J A Werner
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20

6.  Scientific impact of studies published in temporarily available radiation oncology journals: a citation analysis.

Authors:  Carsten Nieder; Hans Geinitz; Nicolaus H Andratschke; Anca L Grosu
Journal:  Springerplus       Date:  2015-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.